Cargando…
Recent Progress of Genome Study for Anaplastic Thyroid Cancer
Anaplastic thyroid cancer (ATC) belongs to the most malignant and rapidly progressive human thyroid cancers and its prognosis is very poor. Also, it shows high resistance to cancer treatments, so that effective treatment for ATC has not been found to date, and virtually all patients terminate their...
Autores principales: | Lee, Jieun, Hwang, Jung-Ah, Lee, Eun Kyung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korea Genome Organization
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3704929/ https://www.ncbi.nlm.nih.gov/pubmed/23843772 http://dx.doi.org/10.5808/GI.2013.11.2.68 |
Ejemplares similares
-
Recent advances in the management of anaplastic thyroid cancer
por: De Leo, Simone, et al.
Publicado: (2020) -
Recent Improvements in Genomic and Transcriptomic Understanding of Anaplastic and Poorly Differentiated Thyroid Cancers
por: Yoo, Seong-Keun, et al.
Publicado: (2020) -
Recent advances and emerging therapies in anaplastic thyroid carcinoma
por: Cabanillas, Maria E., et al.
Publicado: (2018) -
Targeting transcriptional regulators for treatment of anaplastic thyroid cancer
por: Lee, Woo Kyung, et al.
Publicado: (2021) -
FOXD3 regulates anaplastic thyroid cancer progression
por: Yin, Huabin, et al.
Publicado: (2017)